Multiple primary malignancies of female genital organs: ways of prevention
https://doi.org/10.17650/1994-4098-2010-0-1-51-54
Abstract
Prevention of cancer and its early diagnosis is today one of the promising lines of oncology. The identification of the hereditary forms of malignancies is particularly urgent, which prevents the development of tumor pathology in apparently healthy individuals the rela- tives of whom have cancers.
About the Authors
Yu. G. Payanidi
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences
Russian Federation
Russian Federation
V. Yu. Selchuk
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences
Russian Federation
Russian Federation
K. I. Zhordania
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences
Russian Federation
Russian Federation
I. G. Komarov
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences
Russian Federation
Russian Federation
T. P. Kazubskaya
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences
Russian Federation
Russian Federation
T. V. Nasedkina
V.A. Engelhardt Institute of Molecular Biology, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
O. V. Fedorova
V.A. Engelhardt Institute of Molecular Biology, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
P. Z. Kutalia
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences
Russian Federation
Russian Federation
I. A. Kislichko
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences
Russian Federation
Russian Federation
References
1. Казубская Т.П., Белев Н.Ф., Нефедов М.Д. и др. Клинико-генетический анализ первично-множественных злокачественных новообразований. Рос онкол журн 2007;(2):4—9.
2. Акуленко Л.В., Шабалина Н.В., Манухин И.Б. Современные взгляды на этиопатогенез и профилактику семейного рака органов женской репродуктивной системы (обзор литерату- ры). Пробл репродукц 2000;6(1):14—9.
3. Schiffman M., Castle P.E., Jeronimo J. et al. Human papillomavirus and cervical cancer. Lancet 2007;370:890—907.
4. Antoniou A., Pharoah P., Narod S. et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for fami- ly history: a combined analysis of 22 stud- ies. Am J Hum Genet 2003;72:1117—30.
5. Федорова О.Е., Любченко Л.Н., Паяниди Ю.Г. и др. Использование биочипов при изучении распространенных мутаций в генах BRCA 1/2 и CHEK2 у больных органоспецифическим раком яичников и первично-множественными злокачественными новообразованиями с поражением яичников (российская популяция). Мол биол 2007;41(1):37—42.
6. Papp J., Raicevic L., Milasin J. et al. Germline mutation analysis of BRCA1 and BRSA2 genes in Yugoslav brest/ovarian cancer families. Oncol Rep 1999;(6):1435—8.
7. Lippman S.M., Hawk E.T. Cancer prevention: from 1727 to Milestones of the past 100 years. Cancer Res 2009;69(13):5269—84.
Review
For citations:
Payanidi Yu.G., Selchuk V.Yu., Zhordania K.I., Komarov I.G., Kazubskaya T.P., Nasedkina T.V., Fedorova O.V., Kutalia P.Z., Kislichko I.A. Multiple primary malignancies of female genital organs: ways of prevention. Tumors of female reproductive system. 2010;(1):51-54. (In Russ.) https://doi.org/10.17650/1994-4098-2010-0-1-51-54
Views:
653
Email this article 